Abstract
The success of endodontic treatment depends on the eradication of microorganisms from the root canal system and the prevention of reinfection. The purpose of this investigation was to evaluate the antibacterial and antibiofilm efficacy of N-acetylcysteine (NAC), an antioxidant mucolytic agent, as an intracanal medicament against selected endodontic pathogens. Minimum inhibitory concentrations (MICs) of NAC for Actinomyces naeslundii, Lactobacillus salivarius, Streptococcus mutans, and Enterococcus faecalis were determined using the broth microdilution method. NAC showed antibacterial activity, with MIC values of 0.78–1.56 mg/ml. The effect of NAC on biofilm formation of each bacterium and a multispecies culture consisting of the four bacterial species was assessed by crystal violet staining. NAC significantly inhibited biofilm formation by all the monospecies and multispecies bacteria at minimum concentrations of 0.78–3.13 mg/ml. The efficacy of NAC for biofilm disruption was evaluated by scanning electron microscopy and ATP-bioluminescence quantification using mature multispecies biofilms. Preformed mature multispecies biofilms on saliva-coated hydroxyapatite disks were disrupted within 10 min by treatment with NAC at concentrations of 25 mg/ml or higher. After 24 h of treatment, the viability of mature biofilms was reduced by > 99% compared with the control. Moreover, the biofilm disrupting activity of NAC was significantly higher than that of saturated calcium hydroxide or 2% chlorhexidine solution. Within the limitations of this in vitro study, we conclude that NAC has excellent antibacterial and antibiofilm efficacy against endodontic pathogens and may be used as an alternative intracanal medicament in root canal therapies.
Similar content being viewed by others
References
Atila-Pektas, B., Yurdakul, P., Gülmez, D., and Görduysus, O. 2013. Antimicrobial effects of root canal medicaments against Enterococcus faecalis and Streptococcus mutans. Int. Endod. J. 46, 413–418.
Brändle, N., Zehnder, M., Weiger, R., and Waltimo, T. 2008. Impact of growth conditions on susceptibility of five microbial species to alkaline stress. J. Endod. 34, 579–582.
Bulger, E.M. and Maier, R.V. 2001. Antioxidants in critical illness. Arch. Surg. 136, 1201–1207.
Byström, A., Claesson, R., and Sundqvist, G. 1985. The antibacterial effect of camphorated paramonochlorophenol, camphorated phenol and calcium hydroxide in the treatment of infected root canals. Endod. Dent. Traumatol. 1, 170–175.
Chávez De Paz, L.E., Bergenholtz, G., and Svensäter, G. 2010. The effect of antimicrobials on endodontic biofilm bacteria. J. Endod. 36, 70–77.
Chávez De Paz, L.E., Dahlén, G., Molander, A., Möller, A., and Bergenholtz, G. 2003. Bacteria recovered from teeth with apical periodontitis after antimicrobial endodontic treatment. Int. Endod. J. 36, 500–508.
Clark, W.B., Bammann, L.L., and Gibbons, R.J. 1978. Comparative estimates of bacterial affinities and adsorption sites on hydroxyapatite surfaces. Infect. Immun. 19, 846–853.
Clinical and Laboratory Standards Institute. 2007. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard. 7th ed. Document M11-A7. Clinical and Laboratory Standards Institute, Wayne,PA, USA.
del Prado, G., Ruiz, V., Naves, P., Rodríguez-Cerrato, V., Soriano, F., and del Carmen Ponte, M. 2010. Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-l-cysteine, amoxicillin, erythromycin, and levofloxacin. Diagn. Microbiol. Infect. Dis. 67, 311–318.
Drago, L., De Vecchi, E., Mattina, R., and Romanò, C.L. 2013. Activity of N-acetyl-L-cysteine against biofilm of Staphylococcus aureus and Pseudomonas aeruginosa on orthopedic prosthetic materials. Int. J. Artif. Organs 36, 39–46.
Du, T., Shi, Q., Shen, Y., Cao, Y., Ma, J., Lu, X., Xiong, Z., and Haapasalo, M. 2013. Effect of modified nonequilibrium plasma with chlorhexidine digluconate against endodontic biofilms in vitro. J. Endod. 39, 1438–1443.
Ehsani, M., Moghadamnia, A., Zahedpasha, S., Maliji, G., Haghanifar, S., Mir, S.M., and Kani, N.M. 2012. The role of prophylactic ibuprofen and N-acetylcysteine on the level of cytokines in periapical exudates and the post-treatment pain. Daru. 20, 30.
El-Feky, M.A., El-Rehewy, M.S., Hassan, M.A., Abolella, H.A., Abd El-Baky, R.M., and Gad, G.F. 2009. Effect of ciprofloxacin and Nacetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Pol. J. Microbiol. 58, 261–267.
Elias, S. and Banin, E. 2012. Multi-species biofilms: living with friendly neighbors. FEMS Microbiol. Rev. 36, 990–1004.
Evans, M., Davies, J.K., Sundqvist, G., and Figdor, D. 2002. Mechanisms involved in the resistance of Enterococcus faecalis to calcium hydroxide. Int. Endod. J. 35, 221–228.
Flemming, H.C. and Wingender, J. 2010. The biofilm matrix. Nat. Rev. Microbiol. 8, 623–633.
Fox, E.S., Brower, J.S., Bellezzo, J.M., and Leingang, K.A. 1997. Nacetylcysteine and alpha-tocopherol reverse the inflammatory response in activated rat Kupffer cells. J. Immunol. 158, 5418–5423.
Gomes, B.P., Souza, S.F., Ferraz, C.C., Teixeira, F.B., Zaia, A.A., Valdrighi, L., and Souza-Filho, F.J. 2003. Effectiveness of 2% chlorhexidine gel and calcium hydroxide against Enterococcus faecalis in bovine root dentine in vitro. Int. Endod. J. 36, 267–275.
Goswami, M. and Jawali, N. 2010. N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility. Antimicrob. Agents Chemother. 54, 3529–3530.
Guan, L.L., Hagen, K.E., Tannock, G.W., Korver, D.R., Fasenko, G.M., and Allison, G.E. 2003. Detection and identification of Lactobacillus species in crops of broilers of different ages by using PCRdenaturing gradient gel electrophoresis and amplified ribosomal DNA restriction analysis. Appl. Environ. Microbiol. 69, 6750–6757.
Haapasalo, M., Qian, W., Porteiner, I., and Waltimo, T. 2007. Effects of dentin on the antimicrobial properties of endodontic medicaments. J. Endod. 33, 917–925.
Haapasalo, M., Shen, Y., Qian, W., and Gao, Y. 2010. Irrigation in endodontics. Dent. Clin. North Am. 54, 291–312.
Hall-Stoodley, L., Costerton, J.W., and Stoodley, P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2, 95–108.
Jachlewski, S., Jachlewski, W.D., Linne, U., Bräsen, C., Wingender, J., and Siebers, B. 2015. Isolation of extracellular polymeric substances from biofilms of the thermoacidophilic archaeon Sulfolobus acidocaldarius. Front. Bioeng. Biotechnol. 27, 123.
Jang, E.Y., Kim, M., Noh, M.H., Moon, J.H., and Lee, J.Y. 2016. In vitro effects of polyphosphate against Prevotella intermedia in planktonic phase and biofilm. Antimicrob. Agents Chemother. 60, 818–826.
Jiang, L.M., Hoogenkamp, M.A., van der Sluis, L.W.M., Wesselink, P.R., Crielaard, W., and Deng, D.M. 2011. Resazurin metabolism assay for root canal disinfectant evaluation on dual-species biofilms. J. Endod. 37, 31–35.
Kao, L.W., Kirk, M.A., Furbee, R.B., Mehta, N.H., Skinner, J.R., and Brizendine, E.J. 2003. What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning? Ann. Emerg. Med. 42, 741–750.
Lappas, M., Permezel, M., and Rice, G.E. 2003. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-B deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J. Clin. Endocrinol. Metab. 88, 1723–1729.
Lee, J.K., Chang, S.W., Perinpanayagam, H., Lim, S.M., Park, Y.J., Han, S.H., Baek, S.H., Zhu, Q., Bae, K.S., and Kum, K.Y. 2013a. Antibacterial efficacy of a human ß-defensin-3 peptide on multispecies biofilms. J. Endod. 39, 1625–1629.
Lee, J.K., Park, Y.J., Kum, K.Y., Han, S.H., Chang, S.W., Kaufman, B., Jiang, J., Zhu, Q., Safavi, K., and Spångberg, L. 2013b. Antimicrobial efficacy of a human ß-defensin-3 peptide using an Enterococcus faecalis dentine infection model. Int. Endod. J. 46, 406–412.
Lee, J.Y., Sojar, H.T., Bedi, G.S., and Genco, R.J. 1992. Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis. Infect. Immun. 60, 1662–1670.
Lemos, J.A., Abranches, J., Koo, H., Marquis, R.E., and Burne, R.A. 2010. Protocols to study the physiology of oral biofilms. Methods Mol. Biol. 666, 87–102.
Marchese, A., Bozzolasco, M., Gualco, L., Debbia, E.A., Schito, G.C., and Schito, A.M. 2003. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int. J. Antimicrob. Agents. 22(Suppl 2), 95–100.
Moon, J.H., Jang, E.Y., Shim, K.S., and Lee, J.Y. 2015. In vitro effects of N-acetylcysteine alone and in combination with antibiotics on Prevotella intermedia. J. Microbiol. 53, 321–329.
Nandate, K., Ogata, M., Tamura, H., Kawasaki, T., Sata, T., and Shigematsu, A. 2005. N-Acetyl-cysteine attenuates endotoxin-induced adhesion molecule expression in human whole blood. Anesth. Analg. 100, 1453–1457.
Olofsson, A.C., Hermansson, M., and Elwing, H. 2003. N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl. Environ. Microbiol. 69, 4814–4822.
Pérez-Giraldo, C., Rodríguez-Benito, A., Morán, F.J., Hurtado, C., Blanco, M.T., and Gómez-García, A.C. 1997. Influence of Nacetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J. Antimicrob. Chemother. 39, 643–646.
Peros, W.J. and Gibbons, R.J. 1981. Influence of growth medium on adsorption of Streptococcus mutans, Actinomyces viscosus, and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces. Infect. Immun. 32, 111–117.
Portenier, I., Haapasalo, H., Orstavik, D., Yamauchi, M., and Haapasalo, M. 2002. Inactivation of the antibacterial activity of iodine potassium iodide and chlorhexidine digluconate against Enterococcus faecalis by dentin, dentin matrix, type-I collagen, and heat-killed microbial whole cells. J. Endod. 28, 634–637.
Quah, S.Y., Wu, S., Lui, J.N., Sum, C.P., and Tan, K.S. 2012. N-acetylcysteine inhibits growth and eradicates biofilm of Enterococcus faecalis, J. Endod. 38, 81–85.
Ricucci, D. and Siqueira, J.F. 2010. Biofilms and apical periodontitis: study of prevalence and association with clinical and histopathologic findings. J. Endod. 36, 1277–1288.
Rôças, I.N., Siqueira, J.F, and Santos, K.R. 2004. Association of Enterococcus faecalis with different forms of periradicular diseases. J. Endod. 30, 315–320.
Sadowska, A.M., Manuel-Y-Keenoy, B., and De Backer, W.A. 2007. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm. Pharmacol. Ther. 20, 922.
Schwandt, L.Q., Van Weissenbruch, R., Stokroos, I., Van der Mei, H.C., Busscher, H.J., and Albers, F.W. 2004. Prevention of biofilm formation by dairy products and N-acetylcysteine on voice prostheses in an artificial throat. Acta Oto-laryngol. 124, 726–731.
Shen, Y., Stojicic, S., and Haapasalo, M. 2011. Antimicrobial efficacy of chlorhexidine against bacteria in biofilms at different stages of development J. Endod. 37, 657–661.
Silveira, L.F., Baca, P., Arias-Moliz, M.T., Rodríguez-Archilla, A., and Ferrer-Luque, C.M. 2013. Antimicrobial activity of alexidine alone and associated with N-acetylcysteine against Enterococcus faecalis biofilm. Int. J. Oral Sci. 5, 146–149.
Simmons, W.L. and Dybvig, K. 2007. Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin. Infect. Immun. 75, 3696–3699.
Siqueira, J.F. and Lopes, H.P. 1999. Mechanisms of antimicrobial activity of calcium hydroxide: a critical review. Int. Endod. J. 32, 361–369.
Stojicic. S., Shen, Y., and Haapasalo, M. 2013. Effect of the source of biofilm bacteria, level of biofilm maturation, and type of disinfecting agent on the susceptibility of biofilm bacteria to antibacterial agents J. Endod. 39, 473–477.
Takahashi, N., Ishihara, K., Kimizuka, R., Okuda, K., and Kato, T. 2006. The effects of tetracycline, minocycline, doxycycline and ofloxacin on Prevotella intermedia biofilm. Oral Microbiol. Immunol. 21, 366–371.
Wen, Z.T., Yates, D., Ahn, S.J., and Burne, R.A. 2010. Biofilm formation and virulence expression by Streptococcus mutans are altered when grown in dual-species model. BMC Microbiol. 10, 111.
Wuyts, W.A., Vanaudenaerde, B.M., Dupont, L.J., Demedts, M.G., and Verleden, G.M. 2003. N-acetylcysteine reduces chemokine release via inhibition of p38 MAPK in human airway smooth muscle cells. Eur. Respir. J. 22, 43–49.
Zhao, T. and Liu, Y. 2010. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 10, 140.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moon, JH., Choi, YS., Lee, HW. et al. Antibacterial effects of N-acetylcysteine against endodontic pathogens. J Microbiol. 54, 322–329 (2016). https://doi.org/10.1007/s12275-016-5534-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-016-5534-9